(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Neuroendocrine Tumors pipeline constitutes 55+ key companies continuously working towards developing 60… Read More
Job title: Federal Trade InvestigatorCompany: Federal government of the United StatesJob description: Summary
The position is located in the Bureau of Consumer Protection, Division of Finan… Read More
HMBD-001 is Hummingbird Bioscience’s proprietary anti-HER3 antibody in Phase I/IIa trials in the UK and Phase Ib trials in Australia, targeting multiple solid tumors
The clinical da… Read More
MENLO PARK, Calif.–(BUSINESS WIRE)–MedaSystems, developer of the only purpose-built pharma-physician network to provide patients with access to pre-approval medicine*, today ann… Read More
The FDA approved oral etrasimod (Velsipity) on Friday for treating moderately to severely active ulcerative colitis (UC) in adults, drugmaker Pfizer announced.
Approval of the selective sp… Read More
In a bid to counter the ongoing impeachment process against him, the Deputy Governor of Ondo State, Lucky Aiyedatiwa, has approached the court to seek an injunction to prevent the State Hous… Read More
Global multi-region clinical trials (MRCTs) are complex. Understanding challenges in the execution of global multi-region clinical trials may help sponsors, contract research organizations (… Read More
Seeking Improved Immune Response vs mRNA Vaccine
Full Patient Enrollment Expected Within Six Months
ATLANTA, GA – (NewMediaWire) – August 10, 2023 – GeoVax Labs, I… Read More
Clinical trials form the decisions for regulatory approval of drugs and medical devices and as a result are the most important step of a drug development program. In addition to […]
T… Read More
Seeking Improved Immune Response vs mRNA Vaccine
ATLANTA, GA – (NewMediaWire) – July 20, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company de… Read More
Treatment with at least some biologic drugs significantly reduced 1-year progression of early rheumatoid arthritis (RA) relative to classical small-molecule agents, researchers reported.
P… Read More
In today’s data-driven healthcare landscape, effective exchange and utilization of clinical data are critical for driving innovation, improving patient outcomes, and accelerating medic… Read More
A group of private donors has given $17 million to start the Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine, making it what’s believed to be the first such… Read More
Novaliq, a biopharmaceutical company specializing in ocular therapeutics, recently announced that their product Vevye (cyclosporine ophthalmic solution) 0.1 percent received approval from th… Read More
CHICAGO — A three-drug combination significantly improved progression-free survival (PFS) in newly diagnosed non-BRCA advanced ovarian cancer but raised questions about the cost of… Read More
A major milestone in the treatment of amyotrophic lateral sclerosis (ALS) occurred on April 25, 2023, when the FDA approved tofersen (Qalsody) for patients carrying the disease-causing mut… Read More
– Subjects in Herniorrhaphy Study Dosed– Successful FDA Interactions on Two Pre-clinical Pipeline Products Also Discussed
SAN DIEGO, April 18, 2023 /PRNewswire/ — Cali B… Read More
Professor Abukutsa Mary Oyiela Onyango was born on 20th February 1959 in asmall village called Ematsuli, in Emuhaya Division,in larger Kakamega District inWestern Province, Kenya. She is the… Read More
EditorsDr. David S. Mantus, PhD, worked in the biotechnology and pharmaceutical industry for more than 20 years. He served as vice president, Regulatory Affairs at Cubist Pharmaceutica… Read More
Immunotherapy is one of the most exciting and promising new developments in cancer treatment. By taking advantage of the patient’s immune system to attack tumors, immunotherapy provi… Read More
Nearly three-quarters of all clinical trials will run one month behind during their startup phase, and in that time, sponsors can lose anywhere from US$600,000 to US$8M in revenue for every… Read More
NORTH CHICAGO, Ill., Oct. 21, 2022 /PRNewswire/ — AbbVie (NYSE: ABBV) today announces that the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib 15 mg, onc… Read More
- 44% Objective Response Rate (ORR) with a single dose of ADP-A2M4CD8 in 25 heavily pre-treated patients with late-stage ovarian, urothelial, and head & neck cancers -- Further clinical… Read More
Singapore-based SCG Cell Therapy Pte Ltd (“SCG”) announced that U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for SCG101, an… Read More
AstraZeneca’s long-acting antibody combination (tixagevimab co-packaged with cilgavimab called AZD7442), has received emergency use authorization (EUA) in the US for pre-exposure proph… Read More
LOS ANGELES–(BUSINESS WIRE)–Following approval from the United States Bankruptcy Court for the District of Delaware, Mandos, LLC (Mandos) today announced it has closed the acqui… Read More
weight loss
TOKYO and KENILWORTH, N.J., Aug 12, 2021 – (JCN Newswire) – Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Ca… Read More
In 2019, Xtalks profiled six Parkinson’s biotech companies that were leading the way in disease research and drug development. Two years later, we wanted to check in on the progress th… Read More
The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Data generated through high-t… Read More
The HonorHealth Research Institute and HonorHealth announced today the successful enrollment on a novel combination of atovaquone and azithromycin in patients with moderate-to-severe COVID-1… Read More